Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rang in Aktien #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Aktienkurs
$2.20
Zuletzt synchronisiert: 2026-09-01
Marktkapitalisierung
$253.81M
Veränderung (1 Tag)
10.29%
Veränderung (1 Jahr)
99.67%
Land
CA
Handel Cardiol Therapeutics Inc. (CRDL)

Kategorie

Aktien-Split-Historie für Cardiol Therapeutics Inc. (CRDL)
Die Aktie Cardiol Therapeutics Inc. (Symbol: CRDL) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Sep 02, 2026 statt.
Eine CRDL-Aktie, die vor dem Sep 02, 2026 gekauft wurde, entspricht heute 0 CRDL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber